Related Experiment Videos
cis-Dichlorodiammineplatinum(II) as third-line chemotherapy in advanced ovarian adenocarcinoma
Cancer Treatment Reports
|April 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Crohn's disease for the general physician: presentation and investigations.
British journal of hospital medicine (London, England : 2005)·2017
Crohn's disease for the general physician: management.
British journal of hospital medicine (London, England : 2005)·2017
The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: a personal perspective.
European journal of gynaecological oncology·2008
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
British journal of cancer·2004
Assessment of family cancer history collection and utilization in patient care.
Community genetics·2004
A ten-year remission maintained by 6,272 mg (3,920 mg/m2) cumulative dose of cisplatin-based chemotherapy for recurrent epithelial ovarian cancer.
European journal of gynaecological oncology·2002
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Trial designs for assessing induction, maintenance and other treatment effects on a continuous endpoint.
Journal of biopharmaceutical statistics·2026
First-line management of unresectable hepatocellular carcinoma: clinical perspectives from the CheckMate 9DW study.
Future oncology (London, England)·2026
Spontaneous Regression of Vitreoretinal Lymphoma Lesions: Case Series and Literature Review.
Ocular immunology and inflammation·2026